The Enterprise Value as of June 2026 (TTM) for Sumitomo Pharma Co., Ltd. (DNPUF) is 844.20B

According to Sumitomo Pharma Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 844.20B. This represents a change of -8.70% compared to the average of 924.68B of the last 4 quarters.

Sumitomo Pharma Co., Ltd. (DNPUF) Historical Enterprise Value (quarterly & annually)

How has DNPUF Enterprise Value performed in the past?

The mean historical Enterprise Value of Sumitomo Pharma Co., Ltd. over the last ten years is 715.10B. The current 844.20B Enterprise Value has changed 11.71% with respect to the historical average. Over the past ten years (40 quarters), DNPUF's Enterprise Value was at its highest in in the December 2018 quarter at 1.28T. The Enterprise Value was at its lowest in in the December 2022 quarter at 380.84B.

Sumitomo Pharma Co., Ltd. (DNPUF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sumitomo Pharma Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sumitomo Pharma Co., Ltd. (DNPUF) Average Enterprise Value

How has DNPUF Enterprise Value performed in the past?

The current Enterprise Value of Sumitomo Pharma Co., Ltd. (DNPUF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Sumitomo Pharma Co., Ltd. (DNPUF) Enterprise Value vs. Peers

How is DNPUF’s Enterprise Value compared to its peers?

Sumitomo Pharma Co., Ltd.’s Enterprise Value is greater than Livzon Pharmaceutical Group Inc. (21.05B), greater than Siegfried Holding AG (3.40B), greater than Santen Pharmaceutical Co., Ltd. (524.53B), greater than The United Laboratories International Holdings Limited (7.94B), greater than H. Lundbeck A/S (42.43B), greater than Hikma Pharmaceuticals PLC (5.50B), greater than Welcia Holdings Co., Ltd. (635.50B), greater than Carl Zeiss Meditec AG (2.77B), greater than Carl Zeiss Meditec AG (2.77B), greater than Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (12.30B),

Build a custom stock screener for Sumitomo Pharma Co., Ltd. (DNPUF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sumitomo Pharma Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sumitomo Pharma Co., Ltd. (DNPUF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sumitomo Pharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.